Skip to main content
. 2019 Jan 14;42(2):320–329. doi: 10.1002/clc.23139

Table 5.

Summary of clinical validations of scores

Risk scores Number of studies Total number of participants Recurrences LVA MACE
2MACE 121 2108 X
ABC death risk score 124 23 951 X
ALARMEc 4 14, 19, 32, 35 1630 X
APPLE 616, 18, 20, 31, 39, 50 4641 X X
ATLAS 128 1934 X
BASE‐AF2 315, 18, 21 1779 X
CAAP‐AF 317, 31, 38 3698 X
CHADS2 411, 33, 34, 46 2792 X X X
CHA2DS2‐VASc 233, 34 2307 X X
DR‐FLASH 222, 50 2016 X X
LAGO 129 243 X
MB‐LATER 3 3, 18, 21, 38 1769 X